Related Experiment Video
Updated: Feb 28, 2026

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
[Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Literature review and case report]
William Alejandro Camargo-Ariza1, Silvia Juliana Galvis-Blanco1, Tatiana Del Pilar Camacho-Enciso2
1Facultad de Medicina, Universidad Industrial de Santander, Bucaramanga, Santander, Colombia.
Insights
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited heart condition. This case study details a young woman
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited autosomal dominant condition.
- Histologically characterized by fibrous-adipose tissue replacement of cardiomyocytes.
- ARVC/D predisposes patients to ventricular arrhythmias, right ventricular failure, and sudden cardiac death.
Observation:
- A 23-year-old woman presented with palpitations, chest pain, syncope, and headache during pregnancy.
- She collapsed during a stress test, experiencing sustained monomorphic ventricular tachycardia.
- Cardiac MRI revealed right ventricular dilation, increased trabeculae, and reduced function.
Findings:
- 3D mapping and ablation were performed; isoproterenol infusion induced polymorphic ventricular flutter requiring cardioversion.
- A dual-chamber cardioverter-defibrillator and stellate ganglion ablation were implanted for secondary prevention.
- Applying Task Force criteria confirmed a definitive diagnosis of ARVC/D based on major criteria.
Implications:
- This case highlights the diagnostic challenges and complex management of ARVC/D.
- Early diagnosis and appropriate treatment strategies are crucial for reducing sudden cardiac death risk.
- The case underscores the importance of comprehensive evaluation and adherence to diagnostic criteria.
Abstract:
Arrhythmogenic right ventricular cardiomyopathy/dysplasia is an inherited autosomal dominant disease, with an estimated prevalence of 1:2,500 to 1:5,000, being higher in males (3:1). It is characterised histologically by the substitution of cardiomyocytes for fibrous-adipose tissue, which predisposes to ventricular arrhythmias, right ventricular failure, and sudden cardiac death. The main aim of treatment is to reduce the risk of sudden death and improve the quality of life of patients. The case is presented of a 23 year old woman whose clinical symptoms started with palpitations, chest pain with physical activity, syncope, and headache, 6 years ago during her first pregnancy. Due to an increase in symptomatology, a stress test was performed, during which she collapsed with a sustained monomorphic ventricular tachycardia. A cardiac magnetic resonance scan showed dilation, an increase in trabeculae, and decreased function of the right ventricle. A 3-dimensional mapping and ablation was performed, and during the isoproterenol infusion test, a polymorphic ventricular flutter was generated that required electrical cardioversion. The decision was made to implant a dual chamber cardioverter defibrillator and perform stellate ganglion ablation as secondary prevention. After her discharge, the patient re-consulted many times due to discharges of the device associated with palpitations. A comprehensive review of the patient's medical records was performed, finding characteristics that may suggest arrhythmogenic right ventricular dysplasia. The Task Force criteria was applied, concluding that, as she met more than 2 major criteria, the patient had a definitive diagnosis of this disease.
More Related Videos
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Dysrhythmias I: Introduction

